InsiderClue
Insiders · Profile

FOEHR MATTHEW W

President and CEO at OmniAb · Director at Viking Therapeutics · President and COO at LIGAND PHARMACEUTICALS · and 1 more. Filing since 5 Dec 2012. CIK 0001237556

OABI OmniAb, Inc. President and CEO · 19 trades VKTX Viking Therapeutics, Inc. Director · 7 trades LGND LIGAND PHARMACEUTICALS INC President and COO · 27 trades AIXC AIxCrypto Holdings, Inc. Director · 4 trades
Company
Date
Role
Action
Shares
Amount
Of holding
OABI OmniAb, Inc.
7 Apr 2026
President and CEO
Sold at will
19,244
$28.67K
0.4%
OABI OmniAb, Inc.
18 Feb 2026
President and CEO
Sold at will
30,843
$52.74K
0.7%
OABI OmniAb, Inc.
17 Feb 2026
President and CEO
Sold at will
20,754
$35.28K
0.5%
VKTX Viking Therapeutics, Inc.
2 Jan 2026
Director
Sold at will
16,000
$561.69K
10.8%
OABI OmniAb, Inc.
8 Dec 2025
President and CEO
Sold at will
13,666
$26.79K
0.3%
OABI OmniAb, Inc.
7 Apr 2025
President and CEO
Sold at will
19,382
$38.76K
0.5%
OABI OmniAb, Inc.
19 Feb 2025
President and CEO
Sold at will
19,522
$71.65K
0.5%
OABI OmniAb, Inc.
18 Feb 2025
President and CEO
Sold at will
13,964
$51.39K
0.4%
OABI OmniAb, Inc.
21 Jan 2025
President and CEO
Sold at will
41,811
$135.47K
1.1%
OABI OmniAb, Inc.
9 Dec 2024
President and CEO
Sold at will
13,634
$56.31K
0.4%
OABI OmniAb, Inc.
24 May 2024
President and CEO
Bought
240,000
$1.06M
7.3%
OABI OmniAb, Inc.
22 Mar 2024
President and CEO
Bought
225,000
$1.17M
8.4%
OABI OmniAb, Inc.
12 Dec 2023
Chief Executive Officer
Bought
200,000
$1.01M
8.2%
OABI OmniAb, Inc.
10 Nov 2023
President and CEO
Bought
95,000
$405.52K
4.1%
OABI OmniAb, Inc.
14 Aug 2023
President and CEO
Bought
45,000
$246.60K
2.0%
OABI OmniAb, Inc.
9 Jun 2023
Chief Executive Officer
Bought
115,000
$519.80K
4.7%
OABI OmniAb, Inc.
12 May 2023
Chief Executive Officer
Bought
440,000
$1.50M
22.0%
OABI OmniAb, Inc.
12 Dec 2022
President & CEO
Bought
150,000
$564.77K
8.9%
OABI OmniAb, Inc.
30 Nov 2022
President & CEO
Bought
300,000
$1.02M
21.3%
OABI OmniAb, Inc.
9 Nov 2022
President & CEO
Bought
100,000
$276.16K
7.7%
LGND LIGAND PHARMACEUTICALS INC
13 May 2022
President and COO
Bought
2,500
$206.91K
1.5%
VKTX Viking Therapeutics, Inc.
2 May 2022
Director
Bought
45,000
$111.20K
67.9%
LGND LIGAND PHARMACEUTICALS INC
11 Nov 2021
President and COO
Sold, plan not stated
11,160
$1.82M
6.3%
LGND LIGAND PHARMACEUTICALS INC
4 Aug 2021
President and COO
Sold, plan not stated
8,840
$969.51K
5.1%
VKTX Viking Therapeutics, Inc.
10 Jun 2021
Director
Bought
20,000
$113.80K
43.2%
LGND LIGAND PHARMACEUTICALS INC
4 Feb 2021
President and COO
Sold, plan not stated
44,547
$7.88M
20.9%
LGND LIGAND PHARMACEUTICALS INC
24 Aug 2020
President and COO
Sold, plan not stated
78
$8.65K
0.1%
LGND LIGAND PHARMACEUTICALS INC
21 Aug 2020
President and COO
Sold, plan not stated
7,225
$815.54K
4.4%
VKTX Viking Therapeutics, Inc.
30 Jun 2020
Director
Sold, plan not stated
13,000
$95.55K
33.1%
LGND LIGAND PHARMACEUTICALS INC
27 Feb 2020
President and COO
Sold, plan not stated
7,225
$794.75K
4.5%
LGND LIGAND PHARMACEUTICALS INC
14 Feb 2020
President and COO
Sold, plan not stated
7,225
$692.47K
4.4%
LGND LIGAND PHARMACEUTICALS INC
1 Oct 2018
President and COO
Sold, plan not stated
12,000
$3.29M
10.2%
LGND LIGAND PHARMACEUTICALS INC
4 Sep 2018
President and COO
Sold, plan not stated
12,000
$3.06M
10.4%
AIXC AIxCrypto Holdings, Inc.
17 Aug 2018
Director
Bought
19,751
$40.29K
56.4%
LGND LIGAND PHARMACEUTICALS INC
10 May 2018
President and COO
Sold, plan not stated
8,881
$1.49M
8.1%
LGND LIGAND PHARMACEUTICALS INC
23 Feb 2018
President and COO
Sold, plan not stated
5,444
$832.82K
5.4%
LGND LIGAND PHARMACEUTICALS INC
9 Aug 2017
President and COO
Sold, plan not stated
6,100
$777.82K
6.0%
AIXC AIxCrypto Holdings, Inc.
18 May 2017
Director
Bought
18,000
$11.15K
106%
LGND LIGAND PHARMACEUTICALS INC
12 May 2017
President and COO
Sold, plan not stated
5,621
$630.65K
5.7%
LGND LIGAND PHARMACEUTICALS INC
2 Mar 2017
President and COO
Sold, plan not stated
6,879
$711.21K
7.0%
VKTX Viking Therapeutics, Inc.
15 Nov 2016
Director
Bought
13,000
$15.68K
49.5%
LGND LIGAND PHARMACEUTICALS INC
5 Aug 2016
President and COO
Sold, plan not stated
12,500
$1.53M
13.7%
VKTX Viking Therapeutics, Inc.
13 Apr 2016
Director
Bought
20,000
$24.80K
320%
LGND LIGAND PHARMACEUTICALS INC
17 Mar 2016
President and COO
Sold, plan not stated
6,400
$618.88K
7.7%
AIXC AIxCrypto Holdings, Inc.
8 Jan 2016
Director
Bought
13,000
$21.32K
325%
LGND LIGAND PHARMACEUTICALS INC
26 Jun 2015
President and COO
Sold, plan not stated
12,500
$1.26M
15.1%
AIXC AIxCrypto Holdings, Inc.
24 Jun 2015
Director
Bought
4,000
$20.00K
opened
LGND LIGAND PHARMACEUTICALS INC
22 Jun 2015
President and COO
Sold, plan not stated
23,046
$2.22M
25.3%
VKTX Viking Therapeutics, Inc.
4 May 2015
Director
Bought
6,250
$50.00K
opened
LGND LIGAND PHARMACEUTICALS INC
31 Dec 2014
EVP and COO
Bought
46
$2.08K
0.1%
LGND LIGAND PHARMACEUTICALS INC
10 Oct 2014
EVP and COO
Bought
85
$3.82K
0.2%
LGND LIGAND PHARMACEUTICALS INC
30 Jun 2014
EVP and COO
Bought
428
$18.74K
0.8%
LGND LIGAND PHARMACEUTICALS INC
14 Feb 2014
EVP and COO
Sold, plan not stated
22,500
$1.79M
29.6%
LGND LIGAND PHARMACEUTICALS INC
31 Dec 2013
EVP and COO
Bought
84
$2.85K
0.2%
LGND LIGAND PHARMACEUTICALS INC
12 Dec 2013
EVP and COO
Sold, plan not stated
6,000
$320.40K
11.8%
LGND LIGAND PHARMACEUTICALS INC
28 Jun 2013
EVP and COO
Bought
1,059
$18.38K
2.4%
LGND LIGAND PHARMACEUTICALS INC
5 Dec 2012
EVP and COO
Bought
370
$6.66K
1.0%
57 decisions on file.